首页> 美国卫生研究院文献>other >Cyclopamine-loaded Core-crosslinked Polymeric Micelles Enhance Radiation Response in Pancreatic Cancer and Pancreatic Stellate Cells
【2h】

Cyclopamine-loaded Core-crosslinked Polymeric Micelles Enhance Radiation Response in Pancreatic Cancer and Pancreatic Stellate Cells

机译:装载环巴胺的核心交联聚合物胶束增强胰腺癌和胰腺星状细胞的辐射反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers. Cyclopamine (CPA), a potent inhibitor for sonic hedgehog pathway (SHH), shows great promises in PDAC treatment, including the disruption of tumor-associated stroma, and enhancement of radiation therapy. However, CPA is insoluble in water; therefore requires a nanometric delivery platform to achieve satisfactory performance. We herein encapsulated CPA in a core-crosslinked polymeric micelle system (M-CPA). M-CPA was combined with Cs-137 radiation and evaluated in vitro in PDAC cell lines and a human pancreatic stellate cell line. The results showed M-CPA had higher cytotoxicity than CPA, abolished Gli-1 expression (a key component of SHH), and enhanced the radiation therapy of Cs-137. M-CPA radio-sensitization correlated with its ability to disrupt the repair of radiation-induced DNA damage. These findings indicate that the combination therapy of M-CPA and radiation is an effective strategy to simultaneously treat pancreatic tumors and tumor-associated stroma.
机译:胰腺导管腺癌(PDAC)是最致命的癌症之一。声波刺猬通路(SHH)的强效抑制剂Cyclopamine(CPA)在PDAC治疗中显示出广阔的前景,包括破坏与肿瘤相关的基质和增强放射治疗。但是,CPA不溶于水;因此需要一个纳米级的输送平台才能达到令人满意的性能。我们在此将CPA封装在核心交联的聚合物胶束系统(M-CPA)中。 M-CPA与Cs-137放射线结合使用,并在PDAC细胞系和人胰腺星状细胞系中进行体外评估。结果表明,M-CPA具有比CPA更高的细胞毒性,废除了Gli-1表达(SHH的关键成分),并增强了Cs-137的放射治疗。 M-CPA放射致敏作用与其破坏放射线诱导的DNA损伤修复的能力有关。这些发现表明,M-CPA和放射线的联合疗法是同时治疗胰腺肿瘤和肿瘤相关基质的有效策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号